Increasing Accessibility for Flow Cytometry Applications in Emerging and Established Markets Cytek Muse Micro The Cytek® ...

Teknova & Pluristyx introduce proprietary PluriFreeze cryopreservation system to accelerate the development of cell therapies: Hollister, California Friday, March 21, 2025, 13:00 ...

Today, Cytek Biosciences, Inc. (Nasdaq: CTKB) announced that it has added transformative capabilities to its iconic Cytek® Guava® Muse® cell analyzer ...

Ovation Mental Health, a wholly owned subsidiary of 3LS Ventures, is proud to announce a partnership with the Tennessee School of Beauty to provide critical mental health services for both students ...

Learn more about whether Repligen Corporation or Bio-Techne Corporation is a better investment based on AAII's A+ Investor ...

These pricing compendia provide the official source for all information required to order product, including product manufacturing details, National Drug Codes (NDC) for kit purchase, and kit pricing.

(“Teknova”) (Nasdaq: TKNO), and Pluristyx, Inc., today announced that Pluristyx’s PluriFreeze™ cryopreservation system is available for purchase exclusively from Teknova. Teknova is a leading producer ...

Century Therapeutics has joined the onslaught of cell therapy biotechs taking hits, discontinuing a phase 1 cancer study to ...

In a groundbreaking advancement for families grappling with the challenges of Dravet syndrome, a rare and life-altering form ...

The pharma is paying up to $1 billion to buy the Belgian startup, whose technology it sees as useful in treating cancer and ...

But in December, Beauzile, 21, became the first person in New York State to be made symptom-free of sickle cell disease after undergoing Lyfgenia, a new type of gene therapy that uses stem cell ...

The Japan regenerative medicine and cell & gene therapy cold chain logistics market, valued at USD 60.07 million in 2024, is poised for a significant surge, projected to reach USD 209.84 million by ...